Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

NCT01312337 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Nonsmall Cell Lung Cancer

Interventions

DRUG: salvage iressa

Sponsor

Samsung Medical Center